McCann Health Engagement
As a media agency exclusively focused on healthcare, McCann Health Engagement has deep knowledge and vast experience planning and buying in the pharmaceutical industry specific to HCP and DTC on a global scale. We have experience working on almost every therapeutic category within the healthcare and pharmaceutical landscape.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
CMI Media Group
CMI Media Group, a WPP company, is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and…
Four Agency Worldwide
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with content creators, PR gurus with advertising geniuses & sector specialists…
Havas Lynx
We are the Havas Lynx. Devoted to fresh thinking. Changing the way the world does healthcare communications for the better. Great talent. Great ideas. Great outcomes.
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
Company Details
Latest Content from PMHub
The story behind Chloe Mitchell
Press Releases | April 2, 2019 | Resonant Group
From patient safety to a rising star in the Medical Communications world
Autism Awareness Week
White Papers and Resources | April 2, 2019 | Page & Page Health
Autism awareness week highlights the need to support those suffering from the condition, and their families and carers.
Lucid Group Launch a Pioneering Leadership Programme for its Business Leaders
Press Releases | April 2, 2019 | Lucid Group Communications Limited
Great companies start with great leaders. However effective leadership requires skill, emotional intelligence, and most importantly, on-going self-improvement.With this in mind, Lucid Group has launched a new leadership programme for...
OPEN Health Graduates and the XP Support Group
White Papers and Resources | April 1, 2019 | OPEN Health
During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...
Winners of the HSJ Partnership Awards 2019 unveiled
Press Releases | March 22, 2019 | Wilmington Healthcare
The winners of the HSJ Partnership Awards 2019 were announced on 20 March at a prestigious black-tie awards ceremony at Park Plaza, Westminster.
50 questions for delivering an exceptional healthcare brand experience
White Papers and Resources | March 22, 2019 | Blue Latitude Health
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need
The brand strategy revolution
White Papers and Resources | March 22, 2019 | Blue Latitude Health
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need.
How Medisafe is using AI to improve patient adherence
White Papers and Resources | March 22, 2019 | Blue Latitude Health
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.
Downloadable Pack: Understanding Multiple Sclerosis
White Papers and Resources | March 22, 2019 | Blue Latitude Health
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.
Six factors that drive a multiple sclerosis patient’s choice of disease-modifying therapy
White Papers and Resources | March 22, 2019 | Blue Latitude Health
MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget.